Sujal Shah Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sujal Shah.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sujal Shah. Sujal Shah is Chief Executive Officer in CymaBay Therapeutics, Inc. ($CBAY) and Chief Financial Officer in CymaBay Therapeutics, Inc. ($CBAY) and Interim CEO in CymaBay Therapeutics, Inc. ($CBAY) and Interim President & CEO in CymaBay Therapeutics, Inc. ($CBAY) and President & CEO in CymaBay Therapeutics, Inc. ($CBAY).
Latest Insider Trading Transactions of Sujal Shah
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2021 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Option Exercise | A | 5.78 | 287,000 | 1,658,860 | 287,000 | |
| May 19 2020 | CBAY | CymaBay Therapeuti ... | Shah Sujal | President & CEO | Option Exercise | A | 4.05 | 558,108 | 2,260,337 | 558,108 | |
| Oct 15 2019 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Buy | P | 4.30 | 5,000 | 21,500 | 120,000 | 115 K to 120 K (+4.35 %) |
| Sep 24 2019 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Buy | P | 5.55 | 3,100 | 17,205 | 115,000 | 111.9 K to 115 K (+2.77 %) |
| Sep 24 2019 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Buy | P | 5.50 | 1,900 | 10,450 | 111,900 | 110 K to 111.9 K (+1.73 %) |
| Jan 31 2019 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Option Exercise | A | 8.43 | 328,492 | 2,769,188 | 328,492 | |
| Dec 21 2018 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Buy | P | 6.54 | 10,000 | 65,399 | 110,000 | 100 K to 110 K (+10.00 %) |
| Oct 16 2018 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Buy | P | 9.90 | 5,000 | 49,500 | 100,000 | 95 K to 100 K (+5.26 %) |
| Jul 30 2018 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Buy | P | 10.90 | 5,000 | 54,500 | 95,000 | 90 K to 95 K (+5.56 %) |
| May 15 2018 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Buy | P | 10.65 | 5,000 | 53,250 | 90,000 | 85 K to 90 K (+5.88 %) |
| Jan 26 2018 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Option Exercise | A | 11.69 | 150,000 | 1,753,500 | 150,000 | |
| Oct 31 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | President & CEO | Option Exercise | A | 9.21 | 640,000 | 5,894,400 | 640,000 | |
| Jul 24 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Interim President & ... | Buy | P | 7.35 | 8,033 | 59,043 | 85,000 | 77 K to 85 K (+10.44 %) |
| Jul 24 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Interim President & ... | Buy | P | 7.32 | 100 | 732 | 76,967 | 76.9 K to 77 K (+0.13 %) |
| Jul 24 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Interim President & ... | Buy | P | 7.31 | 576 | 4,211 | 76,867 | 76.3 K to 76.9 K (+0.76 %) |
| Jul 24 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Interim President & ... | Buy | P | 7.30 | 400 | 2,920 | 76,291 | 75.9 K to 76.3 K (+0.53 %) |
| Jul 24 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Interim President & ... | Buy | P | 7.29 | 891 | 6,495 | 75,891 | 75 K to 75.9 K (+1.19 %) |
| May 01 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Interim CEO | Option Exercise | A | 3.48 | 90,000 | 313,200 | 90,000 | |
| Jan 23 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Financial Off ... | Option Exercise | A | 1.72 | 100,000 | 172,000 | 100,000 | |
| Jan 06 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Financial Off ... | Option Exercise | A | 1.82 | 25,000 | 45,500 | 50,000 | |
| Jan 04 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Financial Off ... | Option Exercise | A | 1.82 | 25,000 | 45,500 | 25,000 | |
| Apr 06 2016 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Financial Off ... | Buy | P | 1.39 | 33,000 | 45,870 | 75,000 | 42 K to 75 K (+78.57 %) |
| Apr 06 2016 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Financial Off ... | Buy | P | 1.39 | 22,000 | 30,580 | 42,000 | 20 K to 42 K (+110.00 %) |
| Jan 28 2016 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Financial Off ... | Option Exercise | A | 1.06 | 54,000 | 57,240 | 54,000 | |
| May 19 2015 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Financial Off ... | Buy | P | 3.40 | 10,000 | 34,000 | 20,000 | 10 K to 20 K (+100.00 %) |
| Jan 08 2014 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Financial Off ... | Option Exercise | A | 5.00 | 62,566 | 312,830 | 62,566 | |
| Dec 27 2013 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Financial Off ... | Option Exercise | A | 5.00 | 38,917 | 194,585 | 38,917 | |
| Dec 27 2013 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Financial Off ... | Option Exercise | A | 5.00 | 93,106 | 465,530 | 93,106 |
Page: 1